5-amino-1mq and cd38 inhibitor synergy nad+ Selective membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice Frontiers | Nicotinamide N-methyltransferase (NNMT):

Frontiers Nicotinamide N methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS driven AML: Cell Metabolism Nicotinamide N methyltransferase as a potential therapeutic target for neurodegenerative disorders: Mechanisms, challenges, and future directions ScienceDirect Rapid Discovery of CD38 Inhibitor via DNA Encoded Natural Product Library Screening Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target

SKU: 88345399465 · From vanierexcavation.com